Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
about
MicroRNA and Heart FailureAir Pollution-Induced Vascular Dysfunction: Potential Role of Endothelin-1 (ET-1) SystemThe influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms.Blockade of endothelin-1 with a novel series of 1,3,6-trisubstituted-2-carboxy-quinol-4-ones controls infection-associated preterm birthPricing and reimbursement of orphan drugs: the need for more transparencyChanges of serum neurohormone after renal sympathetic denervation in dogs with pacing-induced heart failureSuccessful drug development despite adverse preclinical findings part 2: examples.Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products.The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.Endothelin-1 and the kidney--beyond BP.Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?ETA selective receptor antagonism prevents ventricular remodeling in volume-overloaded rats.Impairment of coronary endothelial cell ET(B) receptor function after short-term inhalation exposure to whole diesel emissions.Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.Rosiglitazone Attenuated Endothelin-1-Induced Vasoconstriction of Pulmonary Arteries in the Rat Model of Pulmonary Arterial Hypertension via Differential Regulation of ET-1 Receptors.Endothelin antagonism and its role in the treatment of hypertension.Potential approaches to reverse or repair renal fibrosis.Pulmonary Hypertension and Cardiopulmonary Exercise in Heart Failure.Drug Treatment of Hypertension: Focus on Vascular Health.Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.Endothelin-1 signalling controls early embryonic heart rate in vitro and in vivo.Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats.Effect of clazosentan, a selective endothelin A receptor antagonist, and tezosentan, a dual endothelin A/B antagonist, on pulsatile shear stress induced constriction of the iliac in the anaesthetized pig.
P2860
Q26750638-4A6009B9-D805-4337-A1E1-9B2268AB42BFQ28383288-E8E21598-5E47-4739-98C2-289F4094901AQ33897455-75CD3D20-4E3C-4055-A49B-B20045D7DB64Q34162446-DDDB0C24-B948-4548-BF85-04601B720505Q34193502-5431FD17-3D8F-4173-A319-992AC2C9942FQ34769826-F53B4BC9-8695-49A3-AE55-78554C5C194BQ35603965-667D5034-6F5C-4D84-B6A0-92DFF4111DF0Q35715914-ACB6BA3B-E9C6-44E2-AD8A-A50588FC38D2Q35827785-C348721A-235F-42CA-AE0F-C7CC7412D8EBQ36094378-944E7E6F-1536-4309-A514-7BA911C0034FQ36108119-6926E9EB-DDF3-4321-A70F-1739430345AEQ36610320-60FCB6FA-41C7-4874-B96C-E7EB2B4D2518Q36619734-C201315C-BDA6-4E1E-83F6-C065FCB1C290Q36639084-F566908C-98BC-4DE4-990A-1009B471D379Q37264443-F26162E1-C572-49D1-A7F8-FBADE5186717Q37337625-5ECC630C-EE7A-49CD-9D6C-D3E5C9F2B3C4Q37445515-206EAB8D-3A1B-4D2D-83BF-CE33658EA8B8Q37632333-442F8E62-8CE4-417E-8094-6AA5BB4257F1Q38126405-FC498C05-FDD9-4073-A559-AF6E7F6904BFQ38186986-7E968992-81EB-4531-A5B8-F206538F6CC1Q38590116-D1425805-AE88-4328-820F-26B1A7714CFBQ38964342-AB280055-9FB5-4647-93D6-4DB8125CC051Q42829416-28A235CE-749A-4D13-B6BA-F78A03B5E1EFQ44513922-9BC20FCA-3CE2-4AD9-B0B1-BE7DA8BD4F75Q46820258-EE0CE694-91F0-4331-8AF9-3B244AE29688Q48263222-EC31E283-8C61-4780-A2F2-2FCFBA60CE25
P2860
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
@ast
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
@en
type
label
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
@ast
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
@en
prefLabel
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
@ast
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
@en
P2093
P2860
P356
P1433
P1476
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond
@en
P2093
P2860
P304
P356
10.1136/HRT.2004.053991
P407
P577
2005-06-01T00:00:00Z